<unk>  is a recombinant human insulin analog that is FDA approved for the treatment of type 1 diabetes mellitus and type 2 diabetes mellitus.   Common adverse reactions include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema and weight gain.
Insulin glargine
Insulin aspart
Insulin glulisine
Insulin detemir
Insulin lispro
Insulin degludec
Exenatide
Glyburide